Skip to content
Stop using now Drug recall · FDA · Published March 5, 2015

Hospira Recalls Sodium Chloride IV Due to Hair Contamination

Hospira recalls 0.9% Sodium Chloride Injection USP, 250 mL due to human hair found in the solution. Check lot #45-110-C6.

🇺🇸 FDA recall #D-0976-2015DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer

Hospira Inc. is recalling 9,912 VisIV flex containers of 0.9% Sodium Chloride Injection, USP (250 mL) because human hair was confirmed to be present in the solution. The product was distributed nationwide and was available by prescription only. This recall is classified as Class I, indicating a serious health hazard. Read more at govinfonow.com/recall/44908-hospira-inc-recalls-0-9-sodium-chloride-injection-usp-250.

Source Summary by GovInfoNow · govinfonow.com/recall/44908-hospira-inc-recalls-0-9-sodium-chloride-injection-usp-250 · Updated October 12, 2026 · FDA enforcement record: FDA #D-0976-2015

Cite this page

“Hospira Recalls Sodium Chloride IV Due to Hair Contamination.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44908-hospira-inc-recalls-0-9-sodium-chloride-injection-usp-250. Based on FDA recall #D-0976-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0976-2015%22&limit=1).

The FDA announced on March 5, 2015, that Hospira Inc. is recalling 9,912 VisIV flex containers of 0.9% Sodium Chloride Injection due to the presence of particulate matter, specifically human hair. The agency classified this as a Class I recall.

How to tell if you have it

  • Brand: Hospira
  • Product: 0.9% Sodium Chloride Injection, USP, 250 mL
  • Container Type: VisIV Container
  • NDC: 0409-7983-25
  • Lot #: 45-110-C6
  • Expiration Date: 03/01/16

The hazard

The recall addresses the confirmed finding of human hair floating in the IV solution. The FDA classified this as a Class I recall, indicating a high risk of adverse health consequences.

Context

GovInfoNow's records show Hospira Inc. has had 108 other recalls since April 5, 2012. On April 21, 2017, the company recalled Infant Dextrose Injection due to human hair particulates found in syringes. Other recent recalls of similar products include Fresenius Kabi Lidocaine HCl Injection (July 16, 2026) and B. Braun Medical 100mL Sodium Chloride Injection (August 19, 2026).

How to tell if you have this one

Check for 0.9% Sodium Chloride Injection, USP, 250 mL in VisIV Containers manufactured by Hospira Inc., Lake Forest, IL. Look for NDC 0409-7983-25 and Lot # 45-110-C6 with an expiration date of 03/1/16.

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop using the product

    Do not administer any remaining units of the recalled sodium chloride injection to patients.

  2. Identify affected inventory

    Check your stock for VisIV flex containers with NDC 0409-7983-25 and Lot # 45-110-C6.

  3. Contact manufacturer

    Reach out to Hospira Inc. for further instructions on returning or disposing of the product, as specific remedy details are not provided in this record.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 15 months after the firm started it.

1. Firm started the recall: Mar 5, 201512. FDA classified it Class I: May 4, 201523. Published in FDA’s Enforcement Report: May 13, 201534. FDA terminated the recall: Jun 9, 2016420152016
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0976-2015 (March 5, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0976-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA